Movement Alert｜Oscar Health, Inc. Rises 5.33% in Regular Trading, UBS Target Price Upgrade and Oversold Rebound Drive Recovery

Market Focus08-08

On August 7, Oscar Health, Inc. rose 5.33% in regular trading, trading at $27.935/share, with turnover of $232 million. The rebound was driven by UBS raising its target price on the stock and a technical recovery from oversold conditions following the prior session's sharp selloff.

UBS adjusted its price target on Oscar Health, Inc. from $20 to $26 while maintaining a Neutral rating. The upgrade came one day after the stock plunged nearly 12% despite reporting strong Q2 results. The company posted EPS of $1.10, significantly beating the consensus estimate of $0.42-$0.49, while revenue of $4.88 billion surged 70.6% year-over-year, also exceeding expectations. Total membership reached 2.963 million, up 46% year-over-year.

However, the company merely reaffirmed its full-year revenue guidance of $18.7 billion to $19.0 billion without raising the outlook, and warned that ACA membership churn would accelerate in the second half. Pre-market gains of over 16% on earnings day quickly reversed into heavy selling. Today's recovery reflects a combination of the UBS upgrade and technical repair following the steep decline.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1165018228?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-08 03:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165018228","market":"us","top_or_hot":-1,"title":"Movement Alert｜Oscar Health, Inc. Rises 5.33% in Regular Trading, UBS Target Price Upgrade and Oversold Rebound Drive Recovery","media":"Market Focus","content":"<p><p>On August 7, Oscar Health, Inc. rose 5.33% in regular trading, trading at $27.935/share, with turnover of $232 million. The rebound was driven by UBS raising its target price on the stock and a technical recovery from oversold conditions following the prior session's sharp selloff.</p><p>UBS adjusted its price target on Oscar Health, Inc. from $20 to $26 while maintaining a Neutral rating. The upgrade came one day after the stock plunged nearly 12% despite reporting strong Q2 results. The company posted EPS of $1.10, significantly beating the consensus estimate of $0.42-$0.49, while revenue of $4.88 billion surged 70.6% year-over-year, also exceeding expectations. Total membership reached 2.963 million, up 46% year-over-year.</p><p>However, the company merely reaffirmed its full-year revenue guidance of $18.7 billion to $19.0 billion without raising the outlook, and warned that ACA membership churn would accelerate in the second half. Pre-market gains of over 16% on earnings day quickly reversed into heavy selling. Today's recovery reflects a combination of the UBS upgrade and technical repair following the steep decline.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Oscar Health, Inc. Rises 5.33% in Regular Trading, UBS Target Price Upgrade and Oversold Rebound Drive Recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Oscar Health, Inc. Rises 5.33% in Regular Trading, UBS Target Price Upgrade and Oversold Rebound Drive Recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-08 03:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 7, Oscar Health, Inc. rose 5.33% in regular trading, trading at $27.935/share, with turnover of $232 million. The rebound was driven by UBS raising its target price on the stock and a technical recovery from oversold conditions following the prior session's sharp selloff.</p><p>UBS adjusted its price target on Oscar Health, Inc. from $20 to $26 while maintaining a Neutral rating. The upgrade came one day after the stock plunged nearly 12% despite reporting strong Q2 results. The company posted EPS of $1.10, significantly beating the consensus estimate of $0.42-$0.49, while revenue of $4.88 billion surged 70.6% year-over-year, also exceeding expectations. Total membership reached 2.963 million, up 46% year-over-year.</p><p>However, the company merely reaffirmed its full-year revenue guidance of $18.7 billion to $19.0 billion without raising the outlook, and warned that ACA membership churn would accelerate in the second half. Pre-market gains of over 16% on earnings day quickly reversed into heavy selling. Today's recovery reflects a combination of the UBS upgrade and technical repair following the steep decline.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1165018228","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165018228","pubTimestamp":1786132759,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 7, Oscar Health, Inc. rose 5.33% in regular trading, trading at $27.935/share, with turnover of $232 million. The rebound was driven by UBS raising its target price on the stock and a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"走势警报|Oscar Health, Inc. 常规交易中上涨 5.33%，瑞银目标价上调和超卖反弹推动复苏","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"On August 7, Oscar Health, Inc. rose 5.33% in regular trading, trading at $27.935/share, with turnover of $232 million. The rebound was driven by UBS raising its target price on the stock and a technical recovery from oversold conditions following the prior session's sharp selloff.UBS adjusted its price target on Oscar Health, Inc. from $20 to $26 while maintaining a Neutral rating. The upgrade came one day after the stock plunged nearly 12% despite reporting strong Q2 results. The company posted EPS of $1.10, significantly beating the consensus estimate of $0.42-$0.49, while revenue of $4.88 billion surged 70.6% year-over-year, also exceeding expectations. Total membership reached 2.963 million, up 46% year-over-year.However, the company merely reaffirmed its full-year revenue guidance of $18.7 billion to $19.0 billion without raising the outlook, and warned that ACA membership churn would accelerate in the second half. Pre-market gains of over 16% on earnings day quickly reversed into heavy selling. Today's recovery reflects a combination of the UBS upgrade and technical repair following the steep decline.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1165018228","isCrawlerRequest":true}